Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients

Investigation of Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients

This study was planned to investigate the validity and reliability of the Kinesthetic and Visual Imagery Questionnaire in patients with acute stroke.

The objectives of the research are:

1. To evaluate the validity of the Kinesthetic and Visual Imaginery Questionnaire in acute stroke patients aged 50-75 years
2. To evaluate the test-retest reliability of the Kinesthetic and Visual Imaginery Questionnaire in acute stroke patients aged 50-75 years

Motor imagery (MI) is the mental representation of movement without any real body movement. MI is a complex and cognitive process involving the use of sensory and perceptual memories related to motor movements.Various studies using brain imaging techniques have found that during motor imagery, brain areas similar to voluntary movement are activated or the motor cortex can be stimulated. These findings suggest that stroke patients who cannot physically move their limbs can stimulate brain regions responsible for motor movements using motor imagery. The Kinesthetic and Visual Imaginery Questionnaire (KVIQ) is a motor imagery questionnaire developed for people who need to be guided for different reasons and cannot perform complex movements. Evaluate both visual and kinesthetic dimensions of motor images. This study was planned because of the need for evaluation of motor imagery for stroke patients, who mostly have motor and sensory problems.

Inclusion Criteria:

• First stroke and ischemic stroke
• Being in the 50-75 age range
• At least 24 hours after stroke
• Absence of apraxia and aphasia
• Get at least 15 points on the Glasgow Coma Scale
• Score of 24 or more from Mini Mental Test
• Stable vital signs and no improvement in symptoms for 48 hours
• No signs of depression (score 15 or less from the Beck Depression Scale)
• Sitting without support for 1 minute
• Not participating in another concurrent study
• Agree to participate in the study

Exclusion Criteria:

• Other known neurological diseases
• Neglect of the body half
• Presence of cerebellum or mesencephalon lesion
• Drug use affecting cognition
• Patients with epilepsy, seizure attacks
• Those with severe heart and lung disease that may interfere with the study
• Patients with visual or auditory disabilities that might interfere with the study